- Home
- / bioAffinity Technologies
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
bioAffinity Technologies financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$1.3
2024-10-29
Market Capitalization
$21.1 M
2024-10-29
Revenue
$6.2 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|
| Revenue | 4.8K | 7.9M | 9.4M | 6.2M |
| Cost of goods sold | 467.0 | |||
| Gross profit | 4.3K | |||
| Gross profit margin, % | 90.3% | |||
| General and administrative expense | 2.7M | 6.8M | 9.9M | 9.9M |
| Operating expense total | 4.0M | 11.7M | 11.3M | |
| Depreciation and amortization | 504.8K | |||
| EBIT | (4.0M) | (8.0M) | (9.0M) | (10.6M) |
| EBIT margin, % | -83511.5% | -95.6% | -171.6% | |
| Interest income | 46.7K | 122.1K | 17.6K | 23.4K |
| Interest expense | 37.1K | 17.6K | ||
| Pre tax profit | (8.2M) | (7.9M) | (9.0M) | (14.9M) |
| Income tax expense | 2.5K | 21.0K | 11.7K | 44.0K |
| Net Income | (8.2M) | 8.6M | (9.0M) | (14.9M) |
| EPS | (0.7) | (8.7) |